Skip to main content
. 2019 May 14;68(7):1087–1094. doi: 10.1007/s00262-019-02344-6

Fig. 2.

Fig. 2

Examples of PD-L1 IHC staining of FFPE sections from NSCLC patients (× 100): a PD-L1(−) negative; b positive control (× 200), c PD-L1(+) positive, < 50% immunoreactive, d PD-L1(+) positive, > 50% immunoreactive